PATENT CLAIM ANALYSIS

Application Number: 16309999
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "233200"]

Abstract:
The present invention relates to bicyclic pyridine, pyrazine, and pyrimidine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Claim (Index 13):
A method for the treatment or prevention of a disease or condition in a person in need thereof comprising administering a therapeutically effective amount of a compound of  claim 1 , wherein the disease or condition is selected from the group consisting of cancer, autoimmune disorders, cardiovascular diseases, inflammatory diseases, neurodegenerative diseases, allergy, pancreatitis, asthma, multiorgan failure, kidney diseases, platelet aggregation, sperm motility, transplantation rejection, graft rejection, and lung injuries.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15537619', '15537551', '15766887', '15604258', '14872527']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8018354128236005
- 35 USC 102 Novelty (BERT): 0.5790965936569901
- Combined Prediction Score: 0.7795615309069395
- Mean Citation Score: 407.055672
- Max Citation Score: 474.54
- Similarity Product: 447.31962501525874

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test